Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease

Clinical trial NCT02089724 · UNKNOWN

Trial details

NCT number: NCT02089724
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: UNKNOWN
Study type: OBSERVATIONAL

Erdheim-Chester Disease

Start date: 2014-03-01
Primary completion: 2016-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.